Why I remain optimistic on Regis Corporation's ($RGS) successful turnaround through cost-cutting, and growth initiatives under new management.
Tag: stocks
Haw Par Group (SGX:H02) – A Simple Analysis II
I covered Haw Par Group back in 2019. Hence I think it is time to revisit this company which is trading at multi year lows.
The One Book You Must Read to Improve Your Decision-Making Skills
A valuable read for investors looking to improve their decision-making skills in the stock market.
Medpace Holdings Inc (NASDAQ:MEDP) – A High-Growth Investment Opportunity in the CRO Industry
Discover the potential of investing in Medpace Holdings Inc ($MEDP), a leading global CROin the healthcare industry.
uniQure NV (NASDAQ:QURE) – A Prognosis
We study uniQure NV ($QURE), a biotechnology company focused on developing gene therapies for rare diseases.
VolitionRx Limited (NYSE: VNRX) – Enters Commercial Stage for Nu.Q Vet Cancer Test
VolitionRx is commercially introducing a product with a huge addressable market. If successful, the market will rerate the stock.
Boustead SG (SGX:F9D) – Share Price Undervalued, But Lack of Near Term Catalyst
SOTP valuation shows Boustead's share price is undervalued. However, there may be a lack of near term catalyst for a rerate of share price.
uniQure N.V. (NASDAQ:QURE) – World’s Most Expensive Medicine
uniQure's AMT-061 is currently the world's most expensive drug. Here's why investing in $QURE may be rewarded with strong returns.
Insider Buy Superstocks by Jesse Stine
Here is my summary and review of "Insider Buy Superstocks". It has some important concepts to achieve great investment returns.
Five Interesting Earnings Reports At a Pivotal Point For The Market
We look at 5 intriguing earnings report I found during this earnings season